CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results
Yeon Hee Park, Tae Yong Kim, Young-Hyuck Im, Keun-Seok Lee, In Hae Park, Joohyuk Sohn, Soo-Hyeon Lee, Seock-Ah Im, Jee Hyun Kim, Se Hyun Kim, Soo Jung Lee, Su-Jin Koh, Ki Hyeong Lee, Yoon Ji Choi, Eun Kyung Cho, Suee Lee, Seok Yun Kang, Jae Hong Seo, Sung-Bae Kim, Kyung Hae Jung
Cancer Research and Treatment. 2017;49(2):423-429.   Published online 2016 August 3    DOI: https://doi.org/10.4143/crt.2016.191

Excel Download

Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results
Cancer Research and Treatment. 2017;49(2):423-429   Crossref logo
Link1 Link2

Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France
The Breast. 2016;30:73-79   Crossref logo
Link1 Link2

Efficacy and Safety of Intravenous Bisphosphonates for Patients with Breast Cancer Metastatic to Bone: A Review of Randomized, Double-Blind, Phase III Trials
Clinical Breast Cancer. 2005;6(2):125-131   Crossref logo
Link1 Link2

Capecitabine/Bevacizumab Compared to Capecitabine Alone in Pretreated Metastatic Breast Cancer: Results of a Phase III Study)
Clinical Breast Cancer. 2003;3(6):375-377   Crossref logo
Link1 Link2

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Yearbook of Medicine. 2011;2011:117-118   Crossref logo
Link1 Link2

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Yearbook of Oncology. 2011;2011:34-35   Crossref logo
Link1 Link2

Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: A multicenter, cross-sectional study
Asia-Pacific Journal of Clinical Oncology. 2012;8(3):282-291   Crossref logo
Link1

Capecitabine/Cyclophosphamide/Methotrexate for Patients with Metastatic Breast Cancer: A Dose-Finding, Feasibility, and Efficacy Study
Clinical Breast Cancer. 2006;7(4):321-325   Crossref logo
Link1 Link2

Treatment with eribulin mesilate could suppress epithelial– mesenchymal transition (EMT) in tumors of patients with metastatic breast cancer – preliminary report of a prospective study
European Journal of Cancer. 2017;72:S39   Crossref logo
Link1 Link2

Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer
Clinical Breast Cancer. 2010;10(2):160-163   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.